Ustekinumab

Details

Files

Generic Name:

Ustekinumab

Project Status:

Complete

Therapeutic Area:

Arthritis, psoriatic

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

February 10, 2014

Brand Name:

Stelara

Project Line:

Reimbursement Review

Project Number:

SR0359-000

Call for patient/clinician input closed:

April 1, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Psoriatic

Recommendation Type:

Do not list at the submitted price

Final Recommendation:

October 20, 2014

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Pharmacoeconomic Report View PDF

Clinical Report View PDF

Patient Group Input Submissions View PDF

Last Updated : October 30, 2013